Table 1.
Characteristics | No migraine (n=98 010) | Migraine (n=17 531) |
---|---|---|
Mean (SD) age*, years | 34.2 (4.7) | 35.1 (4.5) |
Body mass index†: | ||
<25 | 70.1 | 65.5 |
25 to <30 | 18.3 | 19.9 |
≥30 | 10.9 | 13.9 |
History of hypertension | 4.9 | 8.6 |
History of hypercholesterolemia | 9.7 | 14.7 |
History of diabetes | 0.8 | 1.00 |
Smoking status: | ||
Never | 65.5 | 62.6 |
Past | 21.2 | 22.3 |
Current | 13.2 | 15.0 |
Alcohol consumption, g/day: | ||
0 | 37.1 | 39.4 |
>0 to 14.9 | 58.8 | 57.6 |
≥15 | 3.1 | 2.3 |
Mean (SD) physical activity, METs/week | 24.9 (36.8) | 24.9 (36.7) |
Menopausal status: | ||
Premenopausal | 97.4 | 95.3 |
Postmenopausal | 2.0 | 4.00 |
Dubious/unknown | 0.4 | 0.5 |
Postmenopausal hormone use: | ||
Never | 89.2 | 83.3 |
Past | 6.9 | 9.9 |
Current | 3.3 | 6.1 |
Oral contraceptive use: | ||
Never | 17.1 | 13.4 |
Past | 69.6 | 74.8 |
Current | 13.2 | 11.7 |
Family history of myocardial infarction | 14.3 | 17.5 |
Aspirin use: | ||
<2 days/week | 89.9 | 83.2 |
≥2 days/week | 10.1 | 16.8 |
Acetaminophen (paracetamol) use: | ||
<2 days/week | 80.0 | 66.9 |
≥2 days/week | 20.0 | 33.1 |
Non-steroidal anti-inflammatory drug use: | ||
<2 days/week | 82.6 | 69.7 |
≥2days/week | 17.4 | 30.3 |
Percentages may not add to a 100% because of rounding or missing values.
MET=metabolic equivalent.
*Value is not age adjusted.
†Calculated as weight in kilograms divided by height in meters squared.